Lanean...
Alpha7 nicotinic receptors as therapeutic targets for Parkinson’s disease
Accumulating evidence suggests that CNS α7 nicotinic acetylcholine receptors (nAChRs) are important targets for the development of therapeutic approaches for Parkinson’s disease. This progressive neurodegenerative disorder is characterized by debilitating motor deficits, as well as autonomic problem...
Gorde:
| Argitaratua izan da: | Biochem Pharmacol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600450/ https://ncbi.nlm.nih.gov/pubmed/26093062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2015.06.014 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|